We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

74 hedge funds and large institutions have $215M invested in Lumos Pharma, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 74 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

288% more call options, than puts

Call options by funds: $17.5M | Put options by funds: $4.52M

Holders
74
Holders Change
+74
Holders Change %
–
% of All Funds
2.41%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
74
Increased
–
Reduced
–
Closed
–
Calls
$17.5M
Puts
$4.52M
Net Calls
+$13M
Net Calls Change
+$13M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

LUMO Hedge Fund Activity: Q2 2013 in Review

74 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q2 2013, worth a combined $215M.

Buyers outnumbered sellers: 74 funds opened new LUMO positions and 0 closed out — a net gain of 74 holders — while 0 added to existing stakes and 0 trimmed.

  • 74 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $215M of Lumos Pharma, Inc. Common Stock stock for Q2 2013.
  • 74 funds opened new Lumos Pharma, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +74 holders.

Based on aggregated 13F filings for Q2 2013.